Advanced NMR reported a $1.7 million net loss for its 1995 fiscalyear (end-September), primarily due to losses incurred by itsAdvanced Mammography Systems subsidiary. AMS is awaiting regulatoryclearance to begin marketing a dedicated MR mammography
Advanced NMR reported a $1.7 million net loss for its 1995 fiscalyear (end-September), primarily due to losses incurred by itsAdvanced Mammography Systems subsidiary. AMS is awaiting regulatoryclearance to begin marketing a dedicated MR mammography scanner(SCAN 3/15/95).
Advanced NMR, of Wilmington, MA, said the loss came on revenuesof $8.6 million. ANMR's 1995 fiscal year only included revenuesfor nine months because it changed its fiscal year-end to Sept.30 from Dec. 31 when it merged with imaging services firm MedicalDiagnostics (MDI).
ANMR said the company would have been marginally profitablein fiscal 1995 were it not for losses incurred by Advanced MammographySystems. In addition, ANMR's results included only one month ofrevenue from MDI. ANMR believes MDI will contribute $25 millionin revenue in fiscal 1996.
For the comparable nine months of 1994, ANMR posted revenuesof $5.2 million and a net loss of $1.3 million.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.